Vaccines

04 Jun 2008 Novartis presents full pipeline of novel vaccines addressing significant unmet needs
04 Jun 2008 Bavarian Nordic enters clinical trials with prostate cancer vaccine
03 Jun 2008 Sanofi-Aventis and Oxford Biomedica report encouraging Trovax(R) phase II trial results in Metastatic Renal Cancer
03 Jun 2008 Updated CDX-110 Data in Glioblastoma Multiforme Presented at 44th Annual ASCO Annual Meeting
03 Jun 2008 Transgene's Therapeutic Vaccine TG4010 Meets Primary Endpoint in Non-Small Cell Lung Cancer Phase IIb Trial
03 Jun 2008 Hemispherx Biopharma Press Release for
03 Jun 2008 IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
03 Jun 2008 Stimuvax Phase 1/2 survival data support prior results
03 Jun 2008 Cell Genesys Reports Updated Results From Phase 1 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Used in Combination With Ipilimumab
30 May 2008 New data on MAGE-A3 cancer immuno therapy support novel options of treating non-small cell lung cancer and melanoma
29 May 2008 Wyeth Receives FDA Fast Track Designation for its 13-valent Pneumococcal Conjugate Vaccine for Infants and Toddlers
28 May 2008 Bharat Biotech Announces Successful Completion Of Its Phase I/II Clinical Trial For 116E Rotavirus Vaccine
28 May 2008 Juvaris BioTherapeutics Initiates Phase I Clinical Trial of JVRS-100 Adjuvnated Seasonal Influenza Vaccine
27 May 2008 Bavarian Nordic enters clinical trials with HIV multiantigen vaccine
27 May 2008 Favrille Announces Results from Phase 3 Registration Trial of Specifid in Patients with Follicular B-Cell Non-Hodgkin's Lymphoma
19 May 2008 First pre-pandemic vaccine approved to help protect against pandemic influenza
16 May 2008 Dynavax TOLAMBA(TM) Chamber Study Misses Primary Endpoint; Company Updates 2008 Financial Outlook
15 May 2008 Novavax completes enrollment in phase 1/IIa pandemic influenza vaccine clinical trial
14 May 2008 In a Phase II study, Novartis Meningitis B vaccine has potential to produce a protective immune response in infants[1], the age group most at risk
12 May 2008 Nventa announces additional positive immunological data from HSPE7 phase 1 Cervical Dysplasia trial
09 May 2008 Dutch Authorize Manufacture of Vaccinogen’s New Cancer Vaccine
06 May 2008 Novartis Menveo(R) vaccine shows superior immune response against four types of meningitis disease in pivotal phase III trial
30 Apr 2008 Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
29 Apr 2008 DOR BioPharma Initiates Non-Human Primate Efficacy Studies of RiVaxTM, Its Vaccine Against Ricin Toxin
22 Apr 2008 Biovex agrees SPA with the FDA for a pivotal study with ONCOVEXGM-CSF in metastatic melanoma and announces presentation of phase II results at ASCO

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top